Skip to main content

Articles

Head-to-Head Comparison: Early Insulin Glargine Can Help Achieve Glycemic Target in Type 2 Diabetes
Read More
Cardiometabolic Health
Glycemic Control in Patients with Type 2 Diabetes Significantly Lowers Cardiovascular Disease Risk
Read More
Early Intensive Therapy in Type 2 Diabetes Preserves Beta-Cell Function
Read More
Quality Improvement Programs Enhance Diabetes Care, Especially When Baseline Measures Are Poor
Read More
TODAY Study: New Data, Implications for Young Patients with Diabetes
Read More
1 in 4 Patients with Type 2 Diabetes Does Not Take Basal Insulin as Prescribed
Read More
Achieving Normoglycemia, Even Once, Significantly Reduces Diabetes Risk in Patients with Prediabetes
Read More
FDA Approvals
Diabetes Drug Pipeline: Promising Agents in Late Stages of Development
Read More
Novel Risk Factors for Type 2 Diabetes
Read More
FDA Approvals
Empagliflozin Safe and Effective with or without Metformin, Reduces Weight
Read More
Page 194 of 244
Results 1931 - 1940 of 2434